Showing results (411-420 of 517) with videos related to

Sort By:
Pageof 52
Infection and Immunity|November 13, 2024
Tail-specific protease is an essential Chlamydia virulence factor that mediates the differentiation of elementary bodies into reticulate bodiesArkaprabha Banerjee, Kaylee R Jacobs, Yihui Wang, et al.
Toxicologic Pathology|April 15, 2016
Proceedings of the 2015 National Toxicology Program Satellite SymposiumSusan A Elmore, Cindy A Farman, James R Hailey, et al.
Sexually Transmitted Diseases|June 10, 2021
Prevalence of Chlamydia trachomatis Infection in Young Women and Associated PredictorsKanupriya Gupta, Sally A Harrison, Nkele A Davis, et al.
Toxicologic Pathology|August 21, 2013
Toxicity and carcinogenicity studies of Ginkgo biloba extract in rat and mouse: liver, thyroid, and nose are targetsCynthia V Rider, Abraham Nyska, Michelle C Cora, et al.
Toxicologic Pathology|December 4, 2023
Scientific and Regulatory Policy Committee Technical Review: Biology and Pathology of Ganglia in Animal Species Used for Nonclinical Safety TestingBindu M Bennet, Ingrid D Pardo, Basel T Assaf, et al.
Early Intervention in Psychiatry|January 29, 2011
Early detection and intervention evaluation for people at high-risk of psychosis-2 (EDIE-2): trial rationale, design and baseline characteristicsAnthony P Morrison, Suzanne L K Stewart, Paul French, et al.
Psychological Medicine|December 27, 2024
A feasibility randomized controlled trial of an individually delivered, peer support intervention to reduce the impact of psychosis stigma and discrimination for people with psychosis: the let's talk studyMelissa Pyle, Patrick W Corrigan, Lisa Wood, et al.
The Lancet. Psychiatry|July 14, 2018
Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trialAnthony P Morrison, Melissa Pyle, Andrew Gumley, et al.
BMC Psychiatry|August 7, 2016
Design and protocol for the Focusing on Clozapine Unresponsive Symptoms (FOCUS) trial: a randomised controlled trialMelissa Pyle, John Norrie, Matthias Schwannauer, et al.
Lancet (London, England)|February 11, 2014
Cognitive therapy for people with schizophrenia spectrum disorders not taking antipsychotic drugs: a single-blind randomised controlled trialAnthony P Morrison, Douglas Turkington, Melissa Pyle, et al.
Pageof 52